Lacritec

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

Linseed Oil, Quantity: 334 mg (Equivalent: linoleic acid, Qty 58.5 mg; Equivalent: oleic acid, Qty 58.5 mg; Equivalent: linolenic acid, Qty 192 mg); Borago officinalis, Quantity: 434 mg (Equivalent: gamma-linolenic acid, Qty 95.5 mg); concentrated fish Omega-3 triglycerides, Quantity: 332.1964 mg (Equivalent: eicosapentaenoic acid, Qty 133.6 mg; Equivalent: docosahexaenoic acid, Qty 66.8 mg)

Disponible depuis:

Stiltec Pty Ltd

DCI (Dénomination commune internationale):

Borago officinalis,concentrated fish Omega-3 triglycerides,Linseed Oil

forme pharmaceutique:

Capsule, soft

Composition:

Excipient Ingredients: glycerol; cochineal; Gelatin; polysorbate 80; titanium dioxide; iron oxide red; purified water; colloidal anhydrous silica; Sunflower Oil; mixed (low-alpha type) tocopherols concentrate; d-alpha-tocopherol

Mode d'administration:

Oral

classe:

Medicine Listed

indications thérapeutiques:

Relieve eye discomfort ; Relieve dry eyes ; Maintain/support healthy eye function ; Maintain/support eye health ; Relieve eye soreness ; Decrease/reduce/relieve watery eyes/excessive lacrimation

Descriptif du produit:

Visual Identification: ;

Statut de autorisation:

Listed

Date de l'autorisation:

2012-05-17